Yayın:
The evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib

Sadeleştirilmiş öğe sayfası
dc.contributor.authorEngür, Selin
dc.contributor.authorDikmen, Miriş
dc.contributor.orcid0000-0003-1534-8117
dc.contributor.orcid0009-0000-1090-0166
dc.date.accessioned2025-11-13T10:01:13Z
dc.date.issued2017-03-22
dc.identifier.doihttps://doi.org/10.1080/17843286.2017.1302623
dc.identifier.endpage398
dc.identifier.issn1784-3286
dc.identifier.issue6
dc.identifier.openalexW2600833804
dc.identifier.startpage391
dc.identifier.urihttps://hdl.handle.net/11421/2918
dc.identifier.urihttps://doi.org/10.1080/17843286.2017.1302623
dc.identifier.volume72
dc.language.isoen
dc.relation.ispartofActa Clinica Belgica
dc.rightsrestrictedAccess
dc.subjectBortezomib
dc.subjectIxazomib
dc.subjectProteasome inhibitor
dc.subjectApoptosis
dc.subjectMedicine
dc.subjectPharmacology
dc.subjectCancer research
dc.subjectProteasome
dc.subjectInternal medicine
dc.subjectMultiple myeloma
dc.subjectBiology
dc.subjectBiochemistry
dc.subjectCarfilzomib
dc.subject.sdg3
dc.titleThe evaluation of the anti-cancer activity of ixazomib on Caco2 colon solid tumor cells, comparison with bortezomib
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5021293880
local.authorid.openalexA5042645402

Dosyalar

Koleksiyonlar

Publications